CAMP Q2 2023 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$71M+9.5% YoY

Gross Profit

$27M38.2% margin

Operating Income

-$3M-3.5% margin

Net Income

-$4M-5.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-9.7%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$774,500

Balance Sheet

Total Assets

$372M

Total Liabilities

$360M

Stockholders' Equity

$12M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$65M	+9.5%
Gross Profit	$27M	$26M	+5.5%
Operating Income	-$3M	-$9M	+73.1%
Net Income	-$4M	-$12M	+66.9%

Revenue Segments

Product

$46M65%

Application Subscriptions And Other Services

$25M35%

Geographic Segments

UNITED STATES

$39M56%

E M E A

$17M24%

Latin America

$7M10%

Asia Pacific

$6M9%

All Other

$1M2%